Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2021-08-27 | 2021-09-30 | 144718 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2022-03-24 | 2022-04-09 | 157250 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Actual shortage | 2022-08-18 | 2022-08-19 | 167162 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2022-08-18 | 2023-01-26 | 167234 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2022-09-22 | 2022-12-22 | 169957 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-02-09 | 2023-06-27 | 184192 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-04-27 | 2023-07-05 | 190689 |
| TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-08 | 2024-03-07 | 194074 |
| TEVA-TOPILENE | 0.05% | LOTION | Resolved | 2023-06-08 | 2023-07-15 | 194088 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-06-16 | 2023-06-27 | 195136 |
| TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-16 | 2023-07-05 | 195189 |
| TEVA-TOPILENE | 0.05% | LOTION | Resolved | 2023-06-19 | 2023-07-05 | 195579 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-06-19 | 2024-03-18 | 195634 |
| TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2023-11-03 | 2023-12-14 | 209119 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-12-07 | 2024-01-11 | 212717 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Actual shortage | 2024-01-18 | 2024-01-25 | 216463 |
| TEVA-TOPISONE | 0.05% | LOTION | Actual shortage | 2024-03-21 | 2024-03-21 | 222944 |
| TEVA-ECTOSONE | 0.05% | LOTION | Actual shortage | 2024-03-28 | 2024-05-03 | 223832 |
| TEVA-TOPISONE | 0.05% | LOTION | Actual shortage | 2024-04-18 | 2024-04-18 | 225480 |
| TEVA-ECTOSONE | 0.1% | LOTION | Actual shortage | 2024-04-25 | 2024-05-03 | 226171 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
| TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117491 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117494 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |